Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
Jian-Min Qin1, Pei-Hao Yin1, Qi Li1, Zhong-Qiu Sa1, Xia Sheng1, Lin Yang1, Tao Huang1, Min Zhang1, Ke-Pan Gao2, Qing-Hua Chen2, Jing-Wei Ma3, He-Bai Shen31Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 2National Pharmaceutical Engineering Research...
Enregistré dans:
Auteurs principaux: | Qin JM, Yin PH, Li Q, Sa ZQ, Sheng X, Yang L, Huang T, Zhang M, Gao KP, Chen QH, Ma JW, Shen HB |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7b84a2aacfd84c3c908b61a3e34a82cb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration
par: Yang B-C, et autres
Publié: (2011) -
In vitro and in vivo evaluation of novel NGR-modified liposomes containing brucine
par: Li S, et autres
Publié: (2017) -
Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
par: Yong Jin, et autres
Publié: (2021) -
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
par: Yuko Kusakabe, et autres
Publié: (2021) -
Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
par: Xia L, et autres
Publié: (2020)